P
8.84
0.43 (5.11%)
| Penutupan Terdahulu | 8.41 |
| Buka | 8.84 |
| Jumlah Dagangan | 655 |
| Purata Dagangan (3B) | 6,208 |
| Modal Pasaran | 604,595,072 |
| Harga / Pendapatan (P/E Ke hadapan) | 169.49 |
| Harga / Jualan (P/S) | 2.37 |
| Harga / Buku (P/B) | 2.77 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 8 May 2025 |
| Margin Keuntungan | -3.98% |
| Margin Operasi (TTM) | 12.66% |
| EPS Cair (TTM) | -0.180 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 14.10% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 50.81% |
| Nisbah Semasa (MRQ) | 3.77 |
| Aliran Tunai Operasi (OCF TTM) | -1.79 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 1.12 M |
| Pulangan Atas Aset (ROA TTM) | -0.52% |
| Pulangan Atas Ekuiti (ROE TTM) | -5.38% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Menurun |
| Biotechnology (Global) | Bercampur | Menurun | |
| Stok | Pharming Group N.V. | Menaik | Menaik |
AISkor Stockmoo
0.6
| Konsensus Penganalisis | 5.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -2.0 |
| Purata Bergerak Teknikal | -2.5 |
| Osilator Teknikal | 2.0 |
| Purata | 0.63 |
|
Pharming Group is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. It is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines to serve the unserved rare disease patients. Its product includes Ruconest. The revenue is generated from the United States. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Core |
| % Dimiliki oleh Institusi | 0.08% |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 39.00 (Oppenheimer, 341.18%) | Beli |
| Median | 38.00 (329.86%) | |
| Rendah | 37.00 (HC Wainwright & Co., 318.55%) | Beli |
| Purata | 38.00 (329.86%) | |
| Jumlah | 2 Beli | |
| Harga Purata @ Panggilan | 8.89 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| HC Wainwright & Co. | 21 Mar 2025 | 37.00 (318.55%) | Beli | 8.84 |
| 20 Mar 2025 | 37.00 (318.55%) | Beli | 8.93 | |
| Oppenheimer | 14 Mar 2025 | 39.00 (341.18%) | Beli | 8.95 |
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |